


Behind the Science: A Conversation with Lamia Sid-Otmane Blog Post
You May Also Like AllVideo Blending Science & Impact in Drug Development: Felix Boakye-Agyeman, Vice President of the QSS Division at CertaraBlending Science & Impact in Drug Development: Felix Boakye-Agyeman,...
Gain Nonclinical Drug Safety Insights with Real-Time Data Analysis Blog Post
Peggy Zorn February 24, 2025 Efficient drug development relies on informed decision-making. For toxicologists, having timely access to nonclinical study data while studies are in progress is a game-changer. Imagine...
Libra Page
Libra™ is AI-powered drug-induced liver injury (DILI) modeling software for precise DILI prediction, reducing animal testing & optimizing preclinical workflows.

Chemaxon Page
A complete cheminformatics workbench for molecule design, property calculation, search, data management, and more.

The Tools You Need to Accelerate Rare Disease Drug Development Blog Post
Download PDF You May Also Like AllRare and Neglected Diseases Rare Oncology Product Launch Playbook: Universal Strategies for Success in the U.S. and EuropeRare Oncology Product Launch Playbook: Universal Strategies...
Certara’s VIP Cocktail Event at Bio-IT World 2025 Blog Post
Date: Thursday, April 3, 2025 Time: 6 – 8:00 PM Location: Del Frisco’s Double Eagle Steak House 250 Northern Ave Suite 200, Boston, MA 02210 Certara is a proud sponsor...
CODEX Atopic Dermatitis (ADERM) Database Blog Post
Download PDF